Tyrphostin Ag-1478

Tyrphostin Ag-1478

SCHEMBL31079458

COc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1O[11CH3]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 13/20 1.00
KDM4E B2RXH2 3/20 1.00
MAPT P10636 3/20 1.00
MAPK1 P28482 3/20 1.00
FBP1 P09467 3/20 1.00
SRC P12931 3/20 1.00
ABL1 P00519 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP3A4 P08684 2/20 1.00
CYP2D6 P10635 2/20 1.00
MAPK14 Q16539 2/20 1.00
MKNK1 Q9BUB5 2/20 1.00
MEN1 O00255 1/20 1.00
GMNN O75496 1/20 1.00
ALDH1A1 P00352 1/20 1.00
LMNA P02545 1/20 1.00
RAF1 P04049 1/20 1.00
TP53 P04637 1/20 1.00
GLA P06280 1/20 1.00
HPGD P15428 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tyrphostin Ag-1478 SCHEMBL93838 1.00 EGFR (1.00) EGFRKDM4EMAPTMAPK1FBP1
Tyrphostin Ag-1478 SCHEMBL29483198 1.00 EGFR (1.00) EGFRKDM4EMAPTMAPK1FBP1
Tyrphostin Ag-1478 SCHEMBL29350062 1.00 EGFR (1.00) EGFRKDM4EMAPTMAPK1FBP1
Tyrphostin Ag-1478 SCHEMBL30362802 0.99 EGFR (1.00) EGFRKDM4EMAPTMAPK1FBP1
Tyrphostin Ag-1478 SCHEMBL5477838 0.99 EGFR (1.00) EGFRKDM4EMAPTMAPK1FBP1
Tyrphostin Ag-1478 SCHEMBL31466723 0.99 EGFR (1.00) EGFRKDM4EMAPTMAPK1FBP1
SCHEMBL21982440 0.94 EGFR (0.89) EGFRKDM4EMAPTMAPK1FBP1
SCHEMBL8258194 0.91 EGFR (0.83) EGFRKDM4EMAPTMAPK1FBP1
SCHEMBL18158234 0.91 EGFR (0.83) EGFRKDM4EMAPTMAPK1FBP1
SCHEMBL1417950 0.90 EGFR (0.82) EGFRKDM4EMAPTMAPK1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112955137-B Combination therapy 米拉蒂治疗股份有限公司 2025-05-13 CN disclosed
CN-118369119-A Combination therapy of KRAS G12D inhibitors and pan ErbB family inhibitors 米拉蒂治疗股份有限公司 2024-07-19 CN disclosed